Wealthspire Advisors (Maryland)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $479K | Buy |
12,534
+3,644
| +41% | +$139K | 0.02% | 279 |
|
|
2020
Q2 | $312K | Buy |
8,890
+1,211
| +16% | +$42.5K | 0.02% | 332 |
|
|
2020
Q1 | $251K | Sell |
7,679
-132
| -2% | -$4.32K | 0.02% | 338 |
|
|
2019
Q4 | $353K | Buy |
7,811
+1,022
| +15% | +$46.2K | 0.02% | 339 |
|
|
2019
Q3 | $276K | Buy |
6,789
+68
| +1% | +$2.76K | 0.02% | 363 |
|
|
2019
Q2 | $289K | Sell |
6,721
-105
| -2% | -$4.52K | 0.02% | 361 |
|
|
2019
Q1 | $262K | Sell |
6,826
-15
| -0.2% | -$576 | 0.02% | 387 |
|
|
2018
Q4 | $242K | Buy |
6,841
+225
| +3% | +$7.96K | 0.02% | 368 |
|
|
2018
Q3 | $255K | Sell |
6,616
-17
| -0.3% | -$655 | 0.02% | 395 |
|
|
2018
Q2 | $217K | Sell |
6,633
-20
| -0.3% | -$654 | 0.02% | 441 |
|
|
2018
Q1 | $182K | Buy |
6,653
+433
| +7% | +$11.8K | 0.02% | 505 |
|
|
2017
Q4 | $154K | Buy |
6,220
+338
| +6% | +$8.37K | 0.02% | 570 |
|
|
2017
Q3 | $172K | Buy |
5,882
+121
| +2% | +$3.54K | 0.02% | 526 |
|
|
2017
Q2 | $160K | Buy |
5,761
+720
| +14% | +$20K | 0.02% | 530 |
|
|
2017
Q1 | $125K | Buy |
5,041
+338
| +7% | +$8.38K | 0.02% | 517 |
|
|
2016
Q4 | $102K | Buy |
4,703
+192
| +4% | +$4.16K | 0.02% | 570 |
|
|
2016
Q3 | $107K | Buy |
4,511
+66
| +1% | +$1.57K | 0.02% | 552 |
|
|
2016
Q2 | $104K | Buy |
4,445
+812
| +22% | +$19K | 0.02% | 528 |
|
|
2016
Q1 | $68K | Buy |
3,633
+167
| +5% | +$3.13K | 0.01% | 623 |
|
|
2015
Q4 | $64K | Buy |
+3,466
| New | +$64K | 0.01% | 647 |
|